FDA approves most expensive gene therapy ever — and here is its connection to Penn
May 28, 2019 at 13:47 PM EDT
The delivery of the Novartis gene therapy for a lethal disease has a strong tie to Penn researchers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.